Significant Breakthroughs in Psychedelic Medicine are Happening at Cybin
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, recently announced that the U.S. Food and Drug Administration (“FDA”) has authorized an Investigational New […]